PCOS: Insulin-Androgen Cycle and GLP-1
PCOS is the most common endocrine disorder in women of reproductive age. Insulin resistance drives androgen excess, which drives further metabolic dysfunction. GLP-1 therapy addresses the insulin resistance root, reducing androgens and restoring cycles.
How PCOS Creates a Self-Reinforcing Cycle and How Weight Loss Treatment Breaks It
PCOS is characterized by the triad of hyperandrogenism (elevated testosterone and DHEA-S), ovulatory dysfunction, and polycystic ovarian morphology on ultrasound. The underlying driver in 70 to 80 percent of cases is insulin resistance. Elevated insulin stimulates ovarian theca cells to produce more androgens, while suppressing sex hormone binding globulin in the liver, which raises free testosterone.
Excess androgens in women with PCOS drive visceral fat accumulation, which worsens insulin resistance, which drives further androgen production. This is a self-reinforcing cycle that dietary restriction alone rarely breaks because the hormonal environment continues to oppose progress. The clinical picture often includes irregular cycles, weight gain that resists dietary effort, hirsutism, acne, and difficulty with fertility.
GLP-1 receptor agonists break this cycle from the insulin resistance side: improving insulin sensitivity reduces the hyperinsulinemia that drives ovarian androgen excess, leading to lower testosterone levels, more regular ovulatory cycles, and addressing the metabolic complications. Studies show GLP-1 therapy in women with PCOS produces 10 to 20 percent weight loss versus 2 to 3 percent with metformin alone. The SELECT trial reinforced these cardiovascular benefits in the broader insulin-resistant population.
PCOS is largely a metabolic disease: The hormonal symptoms of PCOS (irregular cycles, hirsutism, acne) are downstream of insulin resistance and visceral adiposity in most cases. Treating the metabolic root produces broader improvement than treating any single hormonal symptom. Our medical team builds a unified plan rather than fragmenting care across multiple specialists.
How Tactus Health Evaluates PCOS
The evaluation begins with a structured clinical history that documents menstrual history, weight trajectory, hirsutism, acne, fertility status, family history, and prior treatments. Our licensed providers screen for the broader metabolic conditions that almost always cluster with PCOS, including pre-diabetes, fatty liver, and dyslipidemia.
Lab work covers total and free testosterone, DHEA-S, sex hormone binding globulin, LH, FSH, prolactin, fasting glucose, fasting insulin, hemoglobin A1c, lipid panel, comprehensive metabolic panel, TSH, free T4, vitamin D, and a CBC. When labs and clinical picture support GLP-1 therapy, our medical team builds an integrated treatment plan addressing weight, androgens, cycles, and cardiometabolic risk together.
Common Questions About PCOS
Insulin resistance, elevated androgens, and appetite dysregulation from hyperinsulinemia all work against weight loss simultaneously in PCOS. Calorie restriction reduces weight but rarely resolves the underlying hormonal environment, which is why many women with PCOS describe doing everything correctly without seeing meaningful results. GLP-1 therapy addresses the hormonal opposition directly.
Yes. Clinical studies show GLP-1 therapy in women with PCOS produces reductions in testosterone and free androgen index, more regular menstrual cycles, reduced hirsutism scores, and improvements in acne. These hormonal improvements come from addressing the insulin resistance root rather than treating each symptom separately.
Metformin has been used off-label for PCOS for decades and does improve insulin sensitivity and modestly reduces androgens. GLP-1 receptor agonists produce more significant weight loss (10 to 20 percent vs 2 to 3 percent with metformin) and stronger reductions in androgens. For women with PCOS and obesity, GLP-1 therapy is increasingly the preferred option, though metformin remains a useful adjunct in some cases.
Break the Cycle. Address the Root.
Free consultation with our medical team. In-person at Sugar Hill or by telehealth. Labs ordered same day.
